Vitamin A Palmitate Platform
Retinopathy of Prematurity (ROP)
Key Facts
About Advent Therapeutics
Advent Therapeutics is a private, late-stage biotech company founded in 2019 and headquartered in San Diego, with operations at the Pennsylvania Biotechnology Center. The company is developing proprietary, water-miscible formulations of vitamin A palmitate via intramuscular and aerosolized delivery for the prevention and treatment of bronchopulmonary dysplasia (BPD) in preterm infants, a serious condition with no approved therapy. Its programs have received support from the NIH and the Commonwealth of Pennsylvania, positioning it to address a significant unmet need in neonatal intensive care. The leadership team combines expertise in law, finance, R&D, and clinical neonatology.
View full company profileAbout Advent Therapeutics
Advent Therapeutics is a private, late-stage biotech company founded in 2019 and headquartered in San Diego, with operations at the Pennsylvania Biotechnology Center. The company is developing proprietary, water-miscible formulations of vitamin A palmitate via intramuscular and aerosolized delivery for the prevention and treatment of bronchopulmonary dysplasia (BPD) in preterm infants, a serious condition with no approved therapy. Its programs have received support from the NIH and the Commonwealth of Pennsylvania, positioning it to address a significant unmet need in neonatal intensive care. The leadership team combines expertise in law, finance, R&D, and clinical neonatology.
View full company profile